Search Grant Opportunities

DoD Epilepsy Leveraging Research Award

Type: Posted • Opportunity: HT942524ERPLRA

Description

The intent of the FY24 ERP LRA is to leverage ongoing or completed research studies for which PTE was not an original focus and to provide support to expand the research to develop such a focus and increase our understanding of PTE. The project may include basic, translational, and/or clinical research studies. The study must be associated with an ongoing or completed research effort in which PTE is/was not a research priority and for which addition of cohorts, outcomes, assessments, or analysis specific to PTE would be scientifically justified to increase our understanding of PTE. Examples of allowable research include but are not limited to: Secondary analysis of epilepsy surveillance data to evaluate PTE risk; Addition of a chronic TBI cohort in an ongoing preclinical animal study to evaluate seizure outcomes and epileptogenesis; Recruitment/Analysis of a PTE cohort within an ongoing observational longitudinal study for a known concomitant comorbidity of PTE such as depression, cognitive deficits, sleep disorder, etc.

Background
The FY24 ERP challenges the research community to investigate topics related to epileptogenesis for the identification of mechanisms by which brain injury produces epilepsy, study the prevention of PTE and concomitant comorbidities, and develop innovative research tools or biomarkers to better detect, diagnose, or predict the development of PTE.

The ERP encourages collaboration among PTE researchers and urges the scientific community to utilize equitable partnerships with people living with PTE to maximize the translational and impact potential of proposed research.

Grant Details
The intent of the FY24 ERP LRA is to leverage ongoing or completed research studies for which PTE was not an original focus and to provide support to expand the research to develop such a focus and increase our understanding of PTE.

The project may include basic, translational, and/or clinical research studies. The study must be associated with an ongoing or completed research effort in which PTE is/was not a research priority and for which addition of cohorts, outcomes, assessments, or analysis specific to PTE would be scientifically justified to increase our understanding of PTE.

Examples of allowable research include but are not limited to: Secondary analysis of epilepsy surveillance data to evaluate PTE risk; Addition of a chronic TBI cohort in an ongoing preclinical animal study to evaluate seizure outcomes and epileptogenesis; Recruitment/Analysis of a PTE cohort within an ongoing observational longitudinal study for a known concomitant comorbidity of PTE such as depression, cognitive deficits, sleep disorder, etc.

Eligibility Requirements
Extramural and Intramural organizations are eligible to apply, including foreign or domestic organizations, for-profit and non-profit organizations, and public entities. The named Principal Investigator (PI) may be an investigator at any career level. An eligible PI must be employed by or affiliated with an eligible organization. Cost sharing/matching is not an eligibility requirement.

Period of Performance
Awards supported with FY24 funds will be made no later than September 30, 2025. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds.

It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030.

Grant Value
$2.40M is expected to fund approximately three Leveraging Research Award applications. The anticipated direct costs budgeted for the entire period of performance for an FY24 ERP Leveraging Research Award should not exceed $500,000.

Overview

Category of Funding
Science and Technology and other Research and Development
Funding Instruments
Cooperative Agreement
Grant
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 3/25/24 U.S. Army Medical Research Acquisition Activity posted grant opportunity HT942524ERPLRA for DoD Epilepsy Leveraging Research Award with funding of $2.4 million. The grant will be issued under grant program 12.420 Military Medical Research and Development. It is expected that 3 total grants will be made.

Timing

Posted Date
March 25, 2024, 12:00 a.m. EDT
Closing Date
June 20, 2024, 12:00 a.m. EDT Due in 68 Days
Last Updated
March 25, 2024, 12:25 p.m. EDT
Version
1
Archive Date
July 20, 2024

Eligibility

Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Award Sizing

Ceiling
Not Listed
Floor
Not Listed
Estimated Program Funding
$2,400,000
Estimated Number of Grants
3

Contacts

Contact
Susan M Dellinger Supervisory Contract Specialist
Contact Email
Email Description
CDMRP Help Desk
Contact Phone
(301) 619-2090

Documents

Posted documents for HT942524ERPLRA

Potential Applicants and Partners

Awardees that have recently won grants similar to HT942524ERPLRA

Incumbent or Similar Grants

Grants similar to HT942524ERPLRA

Similar Active Opportunities

Open grant opportunities similar to HT942524ERPLRA